Founded in 2010, PDX Pharmaceuticals, also known as Raksa Therapeutics, is a biopharmaceutical company based in Lake Oswego, United States. The company's core mission is to substantially improve healthcare through the development of novel nanotherapeutic pipelines aimed at enhancing cancer-specific immunity. PDX Pharmaceuticals focuses on leveraging cutting-edge nanotechnology platforms to address unmet medical needs, distributing both prescription and proprietary drugs.
PDX Pharmaceuticals has attracted notable investors and industry experts due to its innovative approach to cancer treatment. The company has made significant strides in the biopharmaceutical field, with key achievements including the development of promising nanomaterial drug candidates. Their impact is marked by their commitment to advancing cancer therapy and improving patient outcomes through their specialized nanotechnology solutions.
